TOR1BP1

Across TCGA pan-cancer cohorts, TOR1BP1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of TOR1BP1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where TOR1BP1 RNA is repressed in tumor relative to normal tissue. In most cancer types TOR1BP1 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

KIRC, BRCA, and HNSC are the cancer types where TOR1BP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TOR1BP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	−0.024	.001	6	view →
BRCA	All	All	+0.043	.002	4	view →
HNSC	All	All	+0.059	.021	3	view →
KICH	All	III,IV	−0.084	.009	2	view →
STAD	All	All	+0.083	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

TOR1BP1–KIRC

Open the KIRC breakdown →